Temsirolimus combined with sorafenib in hepatocellular carcinoma: A phase I dose-finding trial with pharmacokinetic and biomarker correlates

R. K. Kelley Dr., H. S. Nimeiri, P. N. Munster, M. T. Vergo, Y. Huang, C. M. Li, J. Hwang, M. F. Mulcahy, B. M. Yeh, P. Kuhn, M. S. Luttgen, J. A. Grabowsky, L. Stucky-Marshall, W. M. Korn, A. H. Ko, E. K. Bergsland, A. B. Benson, A. P. Venook

Research output: Contribution to journalArticlepeer-review

39 Scopus citations

Fingerprint Dive into the research topics of 'Temsirolimus combined with sorafenib in hepatocellular carcinoma: A phase I dose-finding trial with pharmacokinetic and biomarker correlates'. Together they form a unique fingerprint.

Medicine & Life Sciences